Works matching IS 03065251 AND DT 2016 AND VI 82 AND IP 5

Results: 27

Issue Information.

Published in:: British Journal of Clinical Pharmacology, 2016, v. 82, n. 5, p. 1151, doi. 10.1111/bcp.12774
Publication type:: Article

Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders.

Published in:

British Journal of Clinical Pharmacology, 2016, v. 82, n. 5, p. 1245, doi. 10.1111/bcp.12804

By:

Maiese, Kenneth

Publication type:

Article

Potential therapeutic effects of mTOR inhibition in atherosclerosis.

Published in:

British Journal of Clinical Pharmacology, 2016, v. 82, n. 5, p. 1267, doi. 10.1111/bcp.12820

By:

Kurdi, Ammar;
De Meyer, Guido R. Y.;
Martinet, Wim

Publication type:

Article

Therapeutic potential of mTOR inhibitors for targeting cancer stem cells.

Published in:

British Journal of Clinical Pharmacology, 2016, v. 82, n. 5, p. 1180, doi. 10.1111/bcp.12844

By:

Francipane, Maria Giovanna;
Lagasse, Eric

Publication type:

Article

New perspectives on the involvement of mTOR in depression as well as in the action of antidepressant drugs.

Published in:

British Journal of Clinical Pharmacology, 2016, v. 82, n. 5, p. 1280, doi. 10.1111/bcp.12845

By:

Ignácio, Zuleide M.;
Réus, Gislaine Z.;
Arent, Camila O.;
Abelaira, Helena M.;
Pitcher, Meagan R.;
Quevedo, João

Publication type:

Article

Targeting mTOR for the treatment of B cell malignancies.

Published in:

British Journal of Clinical Pharmacology, 2016, v. 82, n. 5, p. 1213, doi. 10.1111/bcp.12888

By:

Lee, Jong‐Hoon Scott;
Vo, Thanh‐Trang;
Fruman, David A.

Publication type:

Article

New perspectives on mTOR inhibitors (rapamycin, rapalogs and TORKinibs) in transplantation.

Published in:

British Journal of Clinical Pharmacology, 2016, v. 82, n. 5, p. 1158, doi. 10.1111/bcp.12893

By:

Waldner, Matthias;
Fantus, Daniel;
Solari, Mario;
Thomson, Angus W.

Publication type:

Article

Potential therapeutic effects of the MTOR inhibitors for preventing ageing and progeria-related disorders.

Published in:

British Journal of Clinical Pharmacology, 2016, v. 82, n. 5, p. 1229, doi. 10.1111/bcp.12928

By:

Evangelisti, Camilla;
Cenni, Vittoria;
Lattanzi, Giovanna

Publication type:

Article

The therapeutic potential of mTOR inhibitors in breast cancer.

Published in:

British Journal of Clinical Pharmacology, 2016, v. 82, n. 5, p. 1189, doi. 10.1111/bcp.12958

By:

Steelman, Linda S.;
Martelli, Alberto M.;
Cocco, Lucio;
Libra, Massimo;
Nicoletti, Ferdinando;
Abrams, Stephen L.;
McCubrey, James A.

Publication type:

Article

New perspectives on the use of mTOR inhibitors in allogeneic haematopoietic stem cell transplantation and graft-versus-host disease.

Published in:

British Journal of Clinical Pharmacology, 2016, v. 82, n. 5, p. 1171, doi. 10.1111/bcp.13022

By:

Lutz, Mathias;
Mielke, Stephan

Publication type:

Article

CYP2C19 and CYP2D6 genotypes in Pacific peoples.

Published in:

British Journal of Clinical Pharmacology, 2016, v. 82, n. 5, p. 1303, doi. 10.1111/bcp.13045

By:

Helsby, Nuala A.

Publication type:

Article

Prospective dose selection and acceleration of paliperidone palmitate 3-month formulation development using a pharmacometric bridging strategy.

Published in:

British Journal of Clinical Pharmacology, 2016, v. 82, n. 5, p. 1364, doi. 10.1111/bcp.13050

By:

Samtani, Mahesh N.;
Nandy, Partha;
Ravenstijn, Paulien;
Remmerie, Bart;
Vermeulen, An;
Russu, Alberto;
D'hoore, Peter;
Baum, Ellen Z.;
Savitz, Adam;
Gopal, Srihari;
Hough, David

Publication type:

Article

Population PK-PD analyses of CD25 occupancy, CD56<sup>bright</sup> NK cell expansion, and regulatory T cell reduction by daclizumab HYP in subjects with multiple sclerosis.

Published in:

British Journal of Clinical Pharmacology, 2016, v. 82, n. 5, p. 1333, doi. 10.1111/bcp.13051

By:

Diao, Lei;
Hang, Yaming;
Othman, Ahmed A.;
Mehta, Devangi;
Amaravadi, Lakshmi;
Nestorov, Ivan;
Tran, Jonathan Q.

Publication type:

Article

Inflammation induced by inhaled lipopolysaccharide depends on particle size in healthy volunteers.

Published in:

British Journal of Clinical Pharmacology, 2016, v. 82, n. 5, p. 1371, doi. 10.1111/bcp.13052

By:

Doyen, Virginie;
Pilcer, Gabrielle;
Dinh, Phong Huy Duc;
Corazza, Francis;
Bernard, Alfred;
Bergmann, Pierre;
Lefevre, Nicolas;
Amighi, Karim;
Michel, Olivier

Publication type:

Article

Abciximab as a bridging strategy to overcome morphine-prasugrel interaction in STEMI patients.

Published in:

British Journal of Clinical Pharmacology, 2016, v. 82, n. 5, p. 1343, doi. 10.1111/bcp.13053

By:

Siller‐Matula, Jolanta M.;
Specht, Simon;
Kubica, Jacek;
Alexopoulos, Dimitrios;
De Caterina, Raffaele;
Hobl, Eva‐Luise;
Jilma, Bernd;
Christ, Günter;
Lang, Irene M.

Publication type:

Article

Drug disposition before and after gastric bypass: fenofibrate and posaconazole.

Published in:

British Journal of Clinical Pharmacology, 2016, v. 82, n. 5, p. 1325, doi. 10.1111/bcp.13054

By:

Gesquiere, Ina;
Hens, Bart;
Van der Schueren, Bart;
Mols, Raf;
Hoon, Jan;
Lannoo, Matthias;
Matthys, Christophe;
Foulon, Veerle;
Augustijns, Patrick

Publication type:

Article

Too many, too few, or too unsafe? Impact of inappropriate prescribing on mortality, and hospitalization in a cohort of community-dwelling oldest old.

Published in:

British Journal of Clinical Pharmacology, 2016, v. 82, n. 5, p. 1382, doi. 10.1111/bcp.13055

By:

Wauters, Maarten;
Elseviers, Monique;
Vaes, Bert;
Degryse, Jan;
Dalleur, Olivia;
Vander Stichele, Robert;
Christiaens, Thierry;
Azermai, Majda

Publication type:

Article

Zinc acetate lozenges for treating the common cold: an individual patient data meta-analysis.

Published in:

British Journal of Clinical Pharmacology, 2016, v. 82, n. 5, p. 1393, doi. 10.1111/bcp.13057

By:

Hemilä, Harri;
Petrus, Edward J.;
Fitzgerald, James T.;
Prasad, Ananda

Publication type:

Article

Design and conduct of early phase drug studies in children: challenges and opportunities.

Published in:

British Journal of Clinical Pharmacology, 2016, v. 82, n. 5, p. 1308, doi. 10.1111/bcp.13058

By:

Rieder, Michael;
Hawcutt, Daniel

Publication type:

Article

Hypoglycaemia when adding sulphonylurea to metformin: a systematic review and network meta-analysis.

Published in:

British Journal of Clinical Pharmacology, 2016, v. 82, n. 5, p. 1291, doi. 10.1111/bcp.13059

By:

Andersen, Stig Ejdrup;
Christensen, Mikkel

Publication type:

Article

Mechanistic target of rapamycin modulation: an emerging therapeutic approach in a wide variety of disease processes.

Published in:

2016

By:

Ferro, Albert

Publication type:

Editorial

NSAID-induced symptomatic hypophosphataemia.

Published in:

British Journal of Clinical Pharmacology, 2016, v. 82, n. 5, p. 1399, doi. 10.1111/bcp.13061

By:

Skeid, Morten Sommerfeldt;
Pedersen‐Bjergaard, Ulrik;
Kristensen, Peter Lommer;
Brandi, Lisbet

Publication type:

Article

Blood pressure-lowering effects of sulodexide depend on albuminuria severity: post hoc analysis of the sulodexide microalbuminuria and macroalbuminuria studies.

Published in:

British Journal of Clinical Pharmacology, 2016, v. 82, n. 5, p. 1351, doi. 10.1111/bcp.13062

By:

Olde Engberink, Rik H. G.;
Heerspink, Hiddo J. L.;
Zeeuw, Dick;
Vogt, Liffert

Publication type:

Article

Delays during the administration of acetylcysteine for the treatment of paracetamol overdose.

Published in:

British Journal of Clinical Pharmacology, 2016, v. 82, n. 5, p. 1358, doi. 10.1111/bcp.13063

By:

Bailey, George P.;
Najafi, Javad;
Elamin, Muhammad E. M. O.;
Waring, W. Stephen;
Thomas, Simon H. L.;
Archer, John R. H.;
Wood, David M.;
Dargan, Paul I.

Publication type:

Article

L-thyroxine doses required for TSH suppression in patients with differentiated thyroid cancer: Effect of a novel UGT1 marker, rs11563250A > G.

Published in:

British Journal of Clinical Pharmacology, 2016, v. 82, n. 5, p. 1402, doi. 10.1111/bcp.13064

By:

Santoro, Ana Beatriz;
Struchiner, Claudio José;
Suarez‐Kurtz, Guilherme

Publication type:

Article

First-in-human study assessing safety, tolerability and pharmacokinetics of BI 409306, a selective phosphodiesterase 9A inhibitor, in healthy males.

Published in:

British Journal of Clinical Pharmacology, 2016, v. 82, n. 5, p. 1315, doi. 10.1111/bcp.13060

By:

Moschetti, Viktoria;
Boland, Katja;
Feifel, Ulrich;
Hoch, Anja;
Zimdahl‐Gelling, Heike;
Sand, Michael

Publication type:

Article

Issue Highlights.

Published in:: 2016
Publication type:: Other